“1000-lb Sisters” fans have been watching Tammy and Amy Slaton’s journey for years, but is the TLC reality series coming to an end? The “1000-lb Sisters” season 7 finale aired in June, and season 8 ...

LB Pharmaceuticals and Celldex have separately stepped up their respective launch preparations by appointing new chief commercial officers, according to a pair of announcements this week. New ...

So Jerry Jones did make a trade after all. The Dallas Cowboys acquired veteran linebacker Logan Wilson in a trade with the Cincinnati Bengals, NFL Network Insider Ian Rapoport reported on Tuesday, per ...

Sept 11 (Reuters) - LB Pharmaceuticals' shares rose 27% in their Nasdaq debut on Thursday, giving the biotech firm a valuation of $381.9 million and opening the door for companies looking to tap the ...

LB Pharmaceuticals’ decision to break cover and go public seems to have paid off, with the company bumping up the number of shares on offer for its Nasdaq listing this morning. The CNS-focused biotech ...

LB Pharmaceuticals raised $285 million in an initial public offering on Wednesday, marking the first sizable new stock offering for a young biotechnology company in more than half a year. With the ...

Sept 10 (Reuters) - LB Pharmaceuticals raised $285 million in its U.S. initial public offering, the biotech firm said on Wednesday, marking the first sizable biotech IPO since February. The New ...

This story was updated on September 11. LB Pharma has finally done it. The biotech IPO stalemate has been broken, with the neuroscience-focused company landing on the Nasdaq Thursday morning in an ...

LB Pharmaceuticals (LBRX), a drug developer focused on neuropsychiatric diseases has announced terms for its initial public offering on Nasdaq seeking a valuation of more than $300M according to a ...

'1000-Lb. Sisters' star Amy Slaton married Brian Lovvorn on Halloween in a ceremony at a haunted inn, which the reality star described as her "dream finally coming true." 1000-Lb. Sisters' Amy Slaton ...

LB Pharmaceuticals Inc (LBRX) has filed to raise $100 million in an IPO of its common stock, according to SEC S-1 registration information. The firm is a clinical-stage biopharma developing a drug ...

Many drugs are available for schizophrenia, but insufficient efficacy and intolerable side effects leave an unmet need that biotech companies are still trying to fill. LB Pharmaceuticals is not ...